Given the role of FoxP3 in promoting tumor growth through immune suppression, it is a potential target for cancer immunotherapy. Strategies include depleting Tregs, inhibiting FoxP3 expression, or blocking its function, thereby enhancing the body's anti-tumor immune response. However, such approaches must be carefully managed to avoid autoimmunity and other adverse effects.
